{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T23:23:39Z","timestamp":1791329019921,"version":"4.3.1"},"reference-count":41,"publisher":"Oxford University Press (OUP)","issue":"suppl_1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,7,15]]},"DOI":"10.1093\/cid\/cis361","type":"journal-article","created":{"date-parts":[[2012,6,19]],"date-time":"2012-06-19T20:43:04Z","timestamp":1340138584000},"page":"S10-S15","source":"Crossref","is-referenced-by-count":227,"title":["Global Burden of Hepatitis C: Considerations for Healthcare Providers in the United States"],"prefix":"10.1093","volume":"55","author":[{"given":"Francisco M.","family":"Averhoff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Glass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Holtzman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2012,7,15]]},"reference":[{"key":"key\n\t\t\t\t20171013233602_CIS361C1","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1177\/0091270003258669","article-title":"Global burden of disease (GBD) for hepatitis C","volume":"44","author":"World Health Organization","year":"2004","journal-title":"J Clin Pharmacol"},{"key":"key\n\t\t\t\t20171013233602_CIS361C2","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.jhep.2006.05.013","article-title":"The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide","volume":"45","author":"Perz","year":"2006","journal-title":"J Hepatol"},{"key":"key\n\t\t\t\t20171013233602_CIS361C3","article-title":"Hepatitis C guidelines pocket card, 2012","author":"American Association for the Study of Liver Diseases"},{"key":"key\n\t\t\t\t20171013233602_CIS361C4","first-page":"1","article-title":"Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease","volume":"47","author":"Centers for Disease Control and Prevention","year":"1998","journal-title":"Morb Mortal Wkly Rep"},{"key":"key\n\t\t\t\t20171013233602_CIS361C5","first-page":"186","article-title":"Hepatitis C","volume-title":"CDC Health Information for International Travel 2012 (yellow book)","author":"Holmberg","year":"2012"},{"key":"key\n\t\t\t\t20171013233602_CIS361C6","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.3748\/wjg.v13.i17.2436","article-title":"Epidemiology of hepatitis C virus infection","volume":"13","author":"Alter","year":"2007","journal-title":"World J Gastroenterol"},{"issue":"Suppl 2","key":"key\n\t\t\t\t20171013233602_CIS361C7","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1478-3231.2011.02540.x","article-title":"A systematic review of hepatitis C virus epidemiology in Asia, Australia and Egypt","volume":"31","author":"Sievert","year":"2011","journal-title":"Liver Int"},{"issue":"Suppl 2","key":"key\n\t\t\t\t20171013233602_CIS361C8","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1478-3231.2011.02539.x","article-title":"A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel","volume":"31","author":"Cornberg","year":"2011","journal-title":"Liver Int"},{"key":"key\n\t\t\t\t20171013233602_CIS361C9","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/S1473-3099(05)70216-4","article-title":"Global epidemiology of hepatitis C virus infection","volume":"5","author":"Shepard","year":"2005","journal-title":"Lancet Infect Dis"},{"key":"key\n\t\t\t\t20171013233602_CIS361C10","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S1473-3099(02)00264-5","article-title":"Epidemiology of chronic hepatitis C virus infection in sub-Saharan Africa","volume":"2","author":"Madhava","year":"2002","journal-title":"Lancet Infect Dis"},{"issue":"Suppl 2","key":"key\n\t\t\t\t20171013233602_CIS361C11","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1111\/j.1478-3231.2011.02538.x","article-title":"Trends and projections of hepatitis C virus epidemiology in Latin America","volume":"31","author":"Kershenobich","year":"2011","journal-title":"Liver Int"},{"issue":"suppl","key":"key\n\t\t\t\t20171013233602_CIS361C12","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.26719\/2010.16.Supp.15","article-title":"Prevalence of hepatitis B and C viral infections in Pakistan: findings of a national survey appealing for effective prevention and control measures","volume":"16","author":"Qureshi","year":"2010","journal-title":"East Mediterr Health J"},{"key":"key\n\t\t\t\t20171013233602_CIS361C13","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1001\/archinternmed.2010.511","article-title":"Incidence and transmission patterns of acute hepatitis C in the United States, 1982\u20132006","volume":"171","author":"Williams","year":"2011","journal-title":"Arch Intern Med"},{"key":"key\n\t\t\t\t20171013233602_CIS361C14","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.drugpo.2007.04.004","article-title":"Global estimates of prevalence of HCV infection among injecting drug users","volume":"18","author":"Aceijas","year":"2007","journal-title":"Int J Drug Policy"},{"key":"key\n\t\t\t\t20171013233602_CIS361C15","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0140-6736(11)61097-0","article-title":"Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews","volume":"378","author":"Nelson","year":"2011","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20171013233602_CIS361C16","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1258\/095646204322637182","article-title":"The global burden of disease attributable to contaminated injections given in health care settings","volume":"15","author":"Hauri","year":"2004","journal-title":"Int J STD AIDS"},{"key":"key\n\t\t\t\t20171013233602_CIS361C17","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.jhep.2006.07.003","article-title":"Transmission of hepatitis C virus by blood transfusions and other medical procedures: a global review","volume":"45","author":"Prati","year":"2006","journal-title":"J Hepatol"},{"key":"key\n\t\t\t\t20171013233602_CIS361C18","article-title":"Global blood safety and availability: facts and figures from the 2007 Blood Safety Survey","author":"World Health Organization","year":"2009"},{"key":"key\n\t\t\t\t20171013233602_CIS361C19","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/S0140-6736(99)06527-7","article-title":"The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt","volume":"355","author":"Frank","year":"2000","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20171013233602_CIS361C20","doi-asserted-by":"crossref","first-page":"14757","DOI":"10.1073\/pnas.1008877107","article-title":"Evidence of intense ongoing endemic transmission of hepatitis C virus in Egypt","volume":"107","author":"Miller","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"key\n\t\t\t\t20171013233602_CIS361C21","first-page":"622","article-title":"The cost of unsafe injections in Pakistan and challenges for prevention program","volume":"16","author":"Altaf","year":"2006","journal-title":"J Coll Physicians Surg Pak"},{"key":"key\n\t\t\t\t20171013233602_CIS361C22","first-page":"1385","article-title":"Establishment of a viral hepatitis surveillance system\u2013Pakistan, 2009\u20132011","volume":"60","author":"Centers for Disease Control and Prevention","year":"2011","journal-title":"Morb Mortal Wkly Rep"},{"key":"key\n\t\t\t\t20171013233602_CIS361C23","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1159\/000076640","article-title":"Sex- and age-specific carriers of hepatitis B and C viruses in Japan estimated by the prevalence in the 3,485,648 first-time blood donors during 1995\u20132000","volume":"47","author":"Tanaka","year":"2004","journal-title":"Intervirology"},{"key":"key\n\t\t\t\t20171013233602_CIS361C24","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1136\/gut.2010.220889","article-title":"Community and personal risk factors for hepatitis C virus infection: a survey of 23,820 residents in Taiwan in 1991\u20132","volume":"60","author":"Lee","year":"2011","journal-title":"Gut"},{"key":"key\n\t\t\t\t20171013233602_CIS361C25","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.cgh.2010.08.024","article-title":"Liver disease in the HIV-infected individual","volume":"8","author":"Price","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"key":"key\n\t\t\t\t20171013233602_CIS361C26","first-page":"945","article-title":"Sexual transmission of hepatitis C virus among HIV-infected men who have sex with men\u2014New York City, 2005\u20132010","volume":"60","author":"Centers for Disease Control and Prevention","year":"2011","journal-title":"MMWR"},{"key":"key\n\t\t\t\t20171013233602_CIS361C27","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1097\/QAD.0b013e3283471cce","article-title":"The hepatitis C epidemic among HIV-positive MSM: incidence estimates from 1990 to 2007","volume":"25","author":"Van der Helm","year":"2011","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20171013233602_CIS361C28","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1136\/gut.51.4.601","article-title":"Hepatitis C and HIV-1 co-infection","volume":"51","author":"Mohsen","year":"2002","journal-title":"Gut"},{"key":"key\n\t\t\t\t20171013233602_CIS361C29","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s11904-010-0071-3","article-title":"HIV\/HCV co-infection: pathogenesis, clinical complications, treatment, and new therapeutic technologies","volume":"8","author":"Operskalski","year":"2011","journal-title":"Curr HIV\/AIDS Rep"},{"key":"key\n\t\t\t\t20171013233602_CIS361C30","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/S0140-6736(00)02681-7","article-title":"Mother-to-child transmission of hepatitis C virus: evidence for preventable peripartum transmission","volume":"356","author":"Gibb","year":"2000","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20171013233602_CIS361C31","volume-title":"Hepatitis and liver cancer: a national strategy for prevention and control of hepatitis B and C","author":"IOM (Institute of Medicine)","year":"2010"},{"key":"key\n\t\t\t\t20171013233602_CIS361C32","article-title":"Egyptian national control strategy for viral hepatitis 2008\u20132012","author":"Arab Republic of Egypt, Ministry of Health and Population National Committee for the Control of Viral Hepatitis"},{"key":"key\n\t\t\t\t20171013233602_CIS361C33","article-title":"Prime Minister's Program for Hepatitis Prevention and Control phase I (2005\u20132010) and phase II (2010\u20132015)","author":"Ministry of Health, Government of Pakistan","year":"2010"},{"key":"key\n\t\t\t\t20171013233602_CIS361C34","doi-asserted-by":"crossref","first-page":"705","DOI":"10.7326\/0003-4819-144-10-200605160-00004","article-title":"The prevalence of hepatitis C virus infection in the United States, 1999 through 2002","volume":"144","author":"Armstrong","year":"2006","journal-title":"Ann Intern Med"},{"key":"key\n\t\t\t\t20171013233602_CIS361C35","article-title":"The cost-effectiveness of birth-cohort screening for hepatitis C antibody in U.S. primary care settings","author":"Rein","year":"2011","journal-title":"Ann Intern Med"},{"key":"key\n\t\t\t\t20171013233602_CIS361C36","article-title":"U.S. legal permanent residents: 2010","author":"Monger","year":"2011"},{"key":"key\n\t\t\t\t20171013233602_CIS361C37","article-title":"Place of birth of the foreign-born population: 2009","author":"Grieco","year":"2010"},{"key":"key\n\t\t\t\t20171013233602_CIS361C38","article-title":"2006\u20132010 American Community Survey: place of birth for the foreign-born population in the United States","author":"US Census Bureau"},{"key":"key\n\t\t\t\t20171013233602_CIS361C39","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1365-2893.2009.01240.x","article-title":"Prevalence of chronic viral hepatitis in people of south Asian ethnicity living in England: the prevalence cannot necessarily be predicted from the prevalence in the country of origin","volume":"17","author":"Uddin","year":"2010","journal-title":"J Viral Hepatitis"},{"key":"key\n\t\t\t\t20171013233602_CIS361C40","article-title":"Viral hepatitis: global policy","author":"World Hepatitis Alliance"},{"key":"key\n\t\t\t\t20171013233602_CIS361C41","article-title":"Sixty-third World Health Assembly resolution WHO 63.18: viral hepatitis","author":"World Health Organization","year":"2010"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/55\/suppl_1\/S10\/20910760\/cis361.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,30]],"date-time":"2019-06-30T03:58:44Z","timestamp":1561867124000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/cid\/article\/55\/suppl_1\/S10\/322362\/Global-Burden-of-Hepatitis-C-Considerations-for"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7,15]]},"references-count":41,"journal-issue":{"issue":"suppl_1","published-online":{"date-parts":[[2012,7,15]]},"published-print":{"date-parts":[[2012,7,15]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/cis361","relation":{},"ISSN":["1537-6591","1058-4838"],"issn-type":[{"value":"1537-6591","type":"electronic"},{"value":"1058-4838","type":"print"}],"subject":[],"published-other":{"date-parts":[[2012,7,15]]},"published":{"date-parts":[[2012,7,15]]}}}